TIGIT
Immunotherapy can be critical to treatment of different types of cancer, claim researchImmune cells can fight cancerous cells says research.
Blow to Roche's cancer immunotherapy prospects as 2nd trial failsIn a study, a combination of tiragolumab and Roche's established Tecentriq drug did not slow disease progression in newly diagnosed cases o...
GSK, iTeos to develop cancer drug in up to $2 billion dealBoston-based iTeos will receive a $625 million upfront payment and is eligible to get up to $1.45 billion more if the programme meets certa...
- Load More